Article
Nearly a third of abnormalities found after first‐trimester screening are different than expected:10‐year experience from a single center
27 Jan 2013
Abstract excerpt
OBJECTIVE: This study aimed to assess the efficacy of first-trimester aneuploidy screening in a single clinical setting. METHODS: Maternal age, nuchal translucency, and maternal serum levels of pregnancy-associated plasma protein A and free beta human chorionic gonadotrophin comprised first-trimester risk assessment for Down syndrome and trisomies 13/18. Means, screen positive rates, detection rates, and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
